Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hemorrhage 1 Carcinoma, Renal Cell 1

Interventions

pembrolizumab 184 Magnetic Resonance Spectroscopy 162 Specimen Handling 134 enzalutamide 125 Nivolumab 118 Gemcitabine 96 Docetaxel 93 Radiosurgery 91 Prednisone 81 Androgen Antagonists 80 Abiraterone Acetate 79 Radiotherapy 75 apalutamide 66 Cisplatin 65 darolutamide 63 Ipilimumab 61 Biopsy 61 abiraterone 58 cabozantinib 55 Carboplatin 55 Leuprolide 52 enfortumab vedotin 51 Radiation 47 Pluvicto 45 Standard of Care 44 atezolizumab 41 Surveys and Questionnaires 38 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 37 X-Rays 37 olaparib 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Surgicel × Genitourinary × 1 year × Clear all

NCT07232927 2025-11-18

HEMOSTA-PN

Ankara University

Phase NA Completed

Carcinoma, Renal Cell, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡